Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Bristol-Myers Squibb Company (BMY)

  • Business News
  • Nov. 14, 2025, 11:59 UTC
  • 23
  • 1 comments

Update on Phase 3 Librexia ACS Trial

Market reaction Comment Full text

Merck & Company Inc (MRK)

  • Business News
  • Nov. 14, 2025, 11:45 UTC
  • 19
  • 1 comments

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

Market reaction Comment Full text

Teleflex Incorporated (TFX)

  • Business News
  • Nov. 14, 2025, 11:30 UTC
  • 9
  • 0 comments

Teleflex - Teleflex to Present at the Jefferies Global Healthcare Conference in London

Market reaction Comment Full text

Teleflex Incorporated (TFX)

  • Business News
  • Nov. 14, 2025, 11:30 UTC
  • 21
  • 1 comments

Teleflex to Present at the Jefferies Global Healthcare Conference in London

Market reaction Comment Full text

Embecta Corp (EMBC)

  • Business News
  • Nov. 14, 2025, 11:30 UTC
  • 20
  • 1 comments

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

Market reaction Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Business News
  • Nov. 14, 2025, 10:45 UTC
  • 20
  • 1 comments

Avadel Receives Unsolicited Proposal from Lundbeck

Market reaction Comment Full text

Riverstone Holdings Limited (AP4)

  • Business News
  • Nov. 14, 2025, 10:09 UTC
  • 10
  • 0 comments

Riverstone Holdings Limited - Announcement

Market reaction Comment Full text

Riverstone Holdings Limited (AP4)

  • Business News
  • Nov. 14, 2025, 09:30 UTC
  • 21
  • 1 comments

Notice Of Record Date

Market reaction Comment Full text

uniQure NV (QURE)

  • Business News
  • Nov. 14, 2025, 09:17 UTC
  • 22
  • 1 comments

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Market reaction Comment Full text

DexCom Inc (DXCM)

  • Business News
  • Nov. 14, 2025, 09:14 UTC
  • 21
  • 1 comments

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text
  • Previous
  • 636
  • 637
  • 638
  • 639
  • 640
  • Next

Search

News categories

  • Technical Exchange News(10958)
  • Event(2420)
  • SEC News(192791)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125600)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin